Sickle cell disease (SCD) is a serious blood-related health disorder that is inherited from one member of a family to another, whereby an individual produces excess hemoglobin, thus causing the development of rigid sickle-shaped cells.

 

Those with SCD have suffer from red blood cells having a short lifespan, thus creating health problems associated with the shortage of red blood cells. SCD symptoms are:

• Severe pain to patients

• Decrease oxygen flow in the body system

• Damage to organs

• Acute chest syndrome

• Stroke

• Premature deaths.

​​​

The cost and demand for sickle cell disease treatment can be high and unaffordable to most people. Normally, they are forced to access a wide range of medications, as the illness affects multiple organs. Therefore, it necessitates the cooperation of different partners to address the problem.

​

Donations from companies, individuals, and government agencies will play a significant role in ensuring that patients with SCD receive the necessary medical attention that would extend their lifespan. These resources will also be used to provide facilities that will improve access to care and research concerning the sickle cell disease.